CVE-2022-20653: high-severity vulnerability in Cisco Email Security Appliance (ESA)
Cisco Email Security Appliance DNS Verification Denial of Service Vulnerability
Published · Updated
E-mail alert when it lands in KEV, gets a public PoC or its score goes up.
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 7.5epss 1.8%
A vulnerability in the DNS-based Authentication of Named Entities (DANE) email verification component of Cisco AsyncOS Software for Cisco Email Security Appliance (ESA) could allow an unauthenticated, remote attacker to cause a denial of service (DoS) condition on an affected device. This vulnerability is due to insufficient error handling in DNS name resolution by the affected software. An attacker could exploit this vulnerability by sending specially formatted email messages that are processed by an affected device. A successful exploit could allow the attacker to cause the device to become unreachable from management interfaces or to process additional email messages for a period of time until the device recovers, resulting in a DoS condition. Continued attacks could cause the device to become completely unavailable, resulting in a persistent DoS condition.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Affected products
Cisco · Cisco Email Security Appliance (ESA)Related CVEs — Cisco Email Security Appliance (ESA)
In the same product, most dangerous first.
CVE-2018-15460HIGHCisco Email Security Appliance URL Filtering Denial of Service VulnerabilityEPSS 2.5%CVE-2018-15453HIGHCisco Email Security Appliance Memory Corruption Denial of Service VulnerabilityEPSS 2.3%CVE-2018-0447—Cisco Email Security Appliance URL Filtering Bypass VulnerabilityEPSS 2.3%CVE-2019-1947HIGHCisco Email Security Appliance Denial of Service VulnerabilityEPSS 1.9%CVE-2019-1983HIGHCisco Email Security Appliance and Cisco Content Security Management Appliance Denial of Service VulnerabilityEPSS 1.9%CVE-2019-1844MEDIUMCisco Email Security Appliance Filter Bypass VulnerabilityEPSS 1.7%